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ENHANCED CHONDROGENIC DIFFERENTIATION OF HUMAN
OSTEOARTHRITIC BONE MARROW ASPIRATES MODIFIED TO
OVEREXPRESS THE TRANSCRIPTION FACTOR SOX9 VIA RAAV-
MEDIATED GENE TRANSFER IN DYNAMIC VERSUS STATIC CULTURE
CONDITIONS
J.K. Venkatesan, A. Rey-Rico, J. Frisch, H. Madry, M. Cucchiarini. Inst. for
Experimental Orthopaedics, Homburg, Saar, Germany
Purpose: Administration of bone marrow aspirates modiﬁed to over-
express reparative genes is a promising approach to remodel damaged
articular cartilage. The goal of this study was to test whether gene
transfer of the chondrogenic SOX9 transcription factor in human
osteoarthritic bone marrow aspirates via the potent, clinically relevant
rAAV vector stimulates the chondrogenic differentiation processes
under mechanical loading culture conditions.
Methods: Bone marrow aspirates were obtained from the distal femurs
of osteoarthritic patients undergoing total knee arthroplasty. All
patients provided informed consent before inclusion in the study. rAAV
vectors were prepared according to a routine protocol using the can-
didate rAAV-FLAG-hsox9 versus control (reporter) rAAV-luc (Fireﬂy
luciferase) constructs. Aspirates were transduced with each vector and
placed in mixed ﬁbrinogen/thrombin for over time (21 days) main-
tenance in dynamic ﬂow rotating bioreactors versus static culture
conditions using chondrogenic medium. Transgene expression was
monitored by immunohistochemistry on parafﬁn-embedded sections
of aspirates that were also stained with safranin O and for immuno-
detection of type-II, type-I, and type-X collagen. The DNA, proteoglycan,
and type-II collagen contents were monitored by Hoechst 22358 assay,
binding to DMMB, and ELISA, respectively. Total RNAwas extracted and
reverse transcription was carried out for cDNA ampliﬁcation via real-
time RT-PCR. Ct values were obtained for SOX9, COL2A1, COL1A1, and
COL10A1, using GAPDH as a control for normalization, and fold induc-
tions relative to luc-treated samples were measured using the 2-DDCt
method. Each condition was performed in triplicate in three experi-
ments. The t-test was employed with P  0.05 considered statistically
signiﬁcant.
Results: Effective sox9 expression was observed in rAAV-FLAG-hsox9-
versus rAAV-luc-treated aspirates both in dynamic and static con-
ditions. Successful chondrogenic differentiation in the aspirates was
observed after 21 days in both types of culture by safranin O staining
and immunodetection of type-II collagen while immunoreactivity to
type-I and -X collagen was less intense when applying rAAV sox9. The
candidate sox9 treatment signiﬁcantly increased the DNA contents in
static culture versus luc but no effects were noted upon the proteo-
glycan and type-II collagen contents. In contrast, application of sox9
increased both the DNA, proteoglycan, and type-II collagen contents in
dynamic culture versus luc, with effects that were more marked than instatic condition. All ﬁndings were corroborated at the gene expression
level via real-time RT-PCR analysis.
Conclusions: Human osteoarthritic bone marrow aspirates can be
modiﬁed via rAAV to overexpress SOX9, leading to enhanced chon-
drogenesis in dynamic culture conditions, showing the value of such an
approach for the future development of novel treatments to repair
damaged articular cartilage.
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EFFECTS OF IGF-I OVEREXPRESSION ON THE CHONDROGENIC
POTENTIAL OF HUMAN BONE MARROW ASPIRATES MODIFIED VIA
RAAV GENE TRANSFER
J. Frisch, A. Rey-Rico, J.K. Venkatesan, H. Madry, M. Cucchiarini. Inst. for
Experimental Orthopaedics, Homburg, Saar, Germany
Purpose: The use of genetically modiﬁed bone marrow aspirates may
provide convenient, one-step therapeutic approaches to regenerate
injured articular cartilage. Here, we examined the effects of over-
expressing the mitogenic and pro-anabolic IGF-I factor via the potent
and safe rAAV gene transfer vectors on the reparative activities of
human osteoarthritic bone marrow aspirates.
Methods: Bone marrow aspirates were obtained from the distal femurs
of osteoarthritic patients undergoing total knee arthroplasty. All
patients provided informed consent before inclusion in the study. rAAV
vectors were prepared according to a routine protocol using the can-
didate rAAV-hIGF-I versus control (reporter) rAAV-lacZ constructs.
Aspirates were transduced with each vector and maintained in chon-
drogenic culture condition for 21 days. Transgene expression was
monitored by immunohistochemistry on parafﬁn-embedded sections
of aspirates that were also stained with toluidine blue and for immu-
nodetection of type-II collagen. The DNA and proteoglycan contents
were monitored by Hoechst 22358 assay and binding to DMMB,
respectively. Total RNA was extracted and reverse transcription was
carried out for cDNA ampliﬁcation via real-time RT-PCR. Ct values were
obtained for SOX9, ACAN, COL2A1, COL1A1, and COL10A1, using GAPDH
as a control for normalization, and fold inductions relative to luc-trea-
ted samples were measured using the 2-DDCt method. Each condition
was performed in duplicate in three experiments. The t-test was
employed with P  0.05 considered statistically signiﬁcant.
Results: Effective IGF-I expression was noted in rAAV-hIGF-I-treated
aspirates vis-a-vis control (rAAV-lacZ) condition. Enhanced chondro-
genic differentiation was observed in the aspirates after 21 days upon
IGF-I gene transfer versus lacZ as seen by a more robust toluidine blue
staining and stronger type-II collagen immunoreactivity. The candidate
IGF-I treatment also signiﬁcantly increased the DNA and proteoglycan
contents in the aspirates. These ﬁndings were corroborated at the gene
expression level by a real-time RT-PCR analysis of SOX9, ACAN, and
COL2A1. Of further note, IGF-I gene transfer also increased the expres-
sion of hypertrophic markers (COL1A1, COL10A1).
Conclusions: rAAV vectors can successfully modify human osteo-
arthritic bone marrow aspirates to overexpress IGF-I, leading to
enhanced metabolic and chondrogenic differentiation activities relative
to control treatment. Regulating IGF-I productionwill be necessary for a
tight control of terminal differentiation and hypertrophy before
adapting the present strategy to treat damaged articular cartilage.
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MICROARRAY COMPARISON BETWEEN HUMAN POLYDACTYLY
CHONDROCYTES AND ADULT KNEE CHONDROCYTES
E. Toyoda y, M. Sato y, T. Ukai y, T. Takahashi y, S. Nakamura z,
R. Matoba z, H. Akutsu x, A. Umezawa x, J. Mochida y. y Tokai Univ., Sch. of
Med., Kanagawa, Japan; zDNA Chip Res. Inc., Kanagawa, Japan; xNatl. Ctr.
for Child Hlth.and Dev., Tokyo, Japan
Purpose: To achieve our goal of treating osteoarthritis (OA) in the knee
through the use of chondrocyte sheets, we have conducted a clinical
study in which autologous chondrocyte sheets are transplanted to the
patient’s knee cartilaginous defect. From November of 2011, eight
patients with OA in the knee received autologous transplantation of
chondrocyte sheets, and as of November of 2014, successful regener-
ation of articular cartilage has been veriﬁed in all cases without any
serious adverse events. Nevertheless, this treatment method of autol-
ogous transplantation requires two surgeries for both harvesting and
transplantation, and limitations on the quantity and quality of cell
